Cygnus aims to begin clinicals with non-invasive OTC blood glucose monitor in mid-1996.
This article was originally published in The Tan Sheet
Executive Summary
CYGNUS THERAPEUTICS' NONINVASIVE BLOOD GLUCOSE MONITOR is expected to enter clinical trials by mid 1996, the company estimated. The wrist watch-type device, based on reverse iontophoresis technology, is still in preliminary stages of development and a clinical protocol for the study has not yet been designed. The study is expected to compare Cygnus' noninvasive device to a standard OTC blood glucose monitor that uses the finger-prick technique.